Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial

BACKGROUND: Palonosetron (Aloxi®, Onicit®) is a pharmacologically unique 5-HT(3) receptor antagonist (RA) approved as a single IV injection for the prevention of nausea and vomiting induced by chemotherapy (CINV) of either moderate or highly emetogenic potential (MEC and HEC, respectively). An oral...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Boccia, Ralph, Grunberg, Steven, Franco-Gonzales, Edwin, Rubenstein, Edward, Voisin, Daniel
Formato: Artigo
Idioma:Inglês
Publicado: Springer-Verlag 2013
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3612585/
https://ncbi.nlm.nih.gov/pubmed/23354552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-012-1691-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares